Challenges Faced Across FDA Greet Mayne In First Year At CFSAN Helm
This article was originally published in The Tan Sheet
Hiring and retaining researchers remains a challenge to CFSAN’s production of robust science to support its regulatory and public health mission, Director Mayne tells FDA’s Science Board. Information technology and bureaucratic hurdles also impede the center’s work.
You may also be interested in...
“We don't have to look much further than our consumer complaint and adverse event systems to see that these upgrades are needed. Each year we receive nearly 10,000 consumer complaints and adverse event reports regarding FDA regulated foods and dietary supplements,” says Susan Mayne.
The mega-retailer is defending a proposed class action in Minnesota federal court over its ‘Target Clean’ marketing and label, which it has awarded "independently" to around 4,000 products in its stores. Consumer plaintiffs allege some offerings contain ingredients on the program's “formulated without” list, as well as other hazardous substances that ought not be in clean products. Pending litigation against Sephora stands to be influential.
FDA introduces Cosmetics Direct for registering manufacturing facilities and listing products, a little more than three months from registration deadlines set by new cosmetics regulations, and provides looks at the forms companies will need to submit. For now at least, the 29 December deadlines stand, notwithstanding stakeholder pressure for extensions or enforcement discretion.